| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.2 | 9e-06 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-05 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |